Skip to main content
Clinical Trials/DRKS00022201
DRKS00022201
Recruiting
Not Applicable

Associations of intestinal microbiota signatures with the efficacy and toxicity of chemotherapy in patients with advanced pancreatic cancer - PaCTx

German Cancer Research Center (DKFZ)0 sites200 target enrollmentJune 18, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C25.9
Sponsor
German Cancer Research Center (DKFZ)
Enrollment
200
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 18, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
German Cancer Research Center (DKFZ)

Eligibility Criteria

Inclusion Criteria

  • Patients with locally advanced or metastatic PDAC or recurrence after primary PDAC resection who receive palliative chemotherapy based on medical indication.
  • \- Persons who have understood the informed consent and signed the written consent form.

Exclusion Criteria

  • \- Refusal by the patient
  • \- Age \< 18 years
  • \- Lack of ability to consent
  • \- Pancreas resection with (neo)adjuvant chemotherapy
  • \- Previous treatment of other malignant cancers

Outcomes

Primary Outcomes

Not specified

Similar Trials